Skip to main content

Apexigen, Inc.

APGNDelisted Aug 23, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001814140

Apexigen, Inc. was delisted on Aug 23, 2023; its insiders filed their last Form 4 on Aug 25, 2023; 17 institutions reported holding it in 13F filings for Q2 2023, worth $1.37M in total; no superinvestor held it.

Q2 2022 vs. Q1 2022

How the institutions holding Apexigen, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of APGN: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders01+1
Shares089.7K+89.7K
Value$0$912.0K+$912.0K

New holders (1)

Institutions that held Apexigen, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to APGN in Q2 2022
InstitutionSharesValue% of portfolio
Tudor Investment Corp Et Al89,746$912.0K0.03%

Sold out (0)

Institutions that held Apexigen, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

None.